Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
Beckman Coulter DxN VERIS Molecular Diagnostics System: Positive Trial Results Reported
Wednesday, October 14, 2015
Unique system proven to improve laboratory workflow and productivity at Sheffield Teaching Hospitals NHS Trust.
Quotient Clinical Expands its Data Sciences Capabilities
Wednesday, September 09, 2015
Company doubles the footprint of its facilities in Edinburgh and Nottingham.
Adeno-Associated Virus Services for Gene Delivery
Tuesday, August 25, 2015
AMSBIO AAV vectors saves users time and increases their efficiency at a cost-effective price.
Vetter Launches Vetter-Ject®
Thursday, July 16, 2015
Novel patented syringe system offers safety and convenience for patients.
XenoTech Adds In Vitro Toxicology to Its Drug Development Services
Wednesday, July 15, 2015
CRO XenoTech, LLC announces the addition of in vitro toxicology to its global drug development service portfolio.
Validive® at the MASCC/ISOO International Symposium
Wednesday, July 01, 2015
Oral presentation of Phase II trial results and meeting with its International Advisory Board.
Electromantles Engineered for Safety
Tuesday, June 30, 2015
Bibby Scientific’s Electromantles® from Electrothermal are engineered for safe and reliable heating of lab chemicals.
Merck Millipore Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
Tuesday, June 16, 2015
Services accelerate time to the clinic by delivering high quality, high expressing cell lines.
Mylan Launches First Bioequivalent Alternative to Seretide® Evohaler®
Friday, June 12, 2015
Mylan becomes the first company to market a generic version of the UK's number one prescribed long-acting beta2-agonist + inhaled corticosteroid pressurized metered-dose inhaler asthma therapy.
Showing Results 1 - 10 of 312
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,800+ scientific and medical posters
4,000+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!